Results 41 to 50 of about 3,931 (193)

Extracorporeal Photopheresis in Dermatology

open access: yesActas Dermo-Sifiliográficas (English Edition), 2009
Extracorporeal photochemotherapy or photopheresis is an immunomodulatory therapy that combines leukapheresis with phototherapy. Blood from the patient is processed to give a leukocyte-rich plasma, which is then treated ex vivo with a photosensitizer and ultraviolet A radiation before reinfusion back into the patient.
L, Pérez-Carmona   +3 more
openaire   +2 more sources

Not all intravenous immunoglobulin preparations are equally well tolerated [PDF]

open access: yes, 2010
Intravenous immunoglobulin (IVIG) is used for many indications beyond the original substitution in primary antibody deficiency. Whereas many reports mention adverse reactions, no comparative data exist concerning the incidence of side-effects among the ...
Benden, C   +6 more
core   +1 more source

European dermatology forum - updated guidelines on the use of extracorporeal photopheresis 2020 - part 1. [PDF]

open access: yes, 2020
Following the first investigational study on the use of extracorporeal photopheresis for the treatment of cutaneous T-cell lymphoma published in 1983, this technology has received continued use and further recognition for additional earlier as well as ...
Arenberger, P.   +27 more
core   +3 more sources

Extracorporeal therapies in oncocritical care and transplant

open access: yesJournal of Pediatric Critical Care
Advances in pediatric hemato-oncology and transplantation have markedly improved outcomes for children with hematologic malignancies, immunodeficiencies, and organ failures. Nonetheless, complications such as graft-versus-host disease (GVHD), multi-organ
Milind Ballal   +2 more
doaj   +1 more source

A Perspective on the Use of NB-UVB Phototherapy vs. PUVA Photochemotherapy [PDF]

open access: yes, 2018
Narrowband UVB (NB-UVB) phototherapy and psoralen-UVA (PUVA) photochemotherapy are widely used phototherapeutic modalities for a range of skin diseases.
Ahmad   +119 more
core   +3 more sources

Nephrogenic systemic fibrosis

open access: yesClinical Case Reports, 2017
Key Clinical Message Nephrogenic systemic fibrosis (NSF) is a fibrosing disorder seen in patients with renal dysfunction, commonly precipitated by administration of gadolinium contrast.
Abhilash Koratala, Vikrampal Bhatti
doaj   +1 more source

A Critical Appraisal of Extracorporeal Photopheresis as a Treatment Modality for Acute and Chronic Graft-Versus-Host Disease [PDF]

open access: yes, 2017
Although significant advances have been made in the biologic understanding of graft-versus-host disease (GVHD) and its treatment options, GVHD remains the single most challenging obstacle to the success of allogeneic hematopoietic cell transplantation ...
Kharfan-Dabaja, Mohamed   +2 more
core   +3 more sources

Recent trends of incidence and mortality of cutaneous lymphomas in Germany

open access: yesJDDG: Journal der Deutschen Dermatologischen Gesellschaft, EarlyView.
Summary Background Primary cutaneous lymphomas (PCL) are primarily composed of cutaneous T‐cell lymphomas (CTCL), followed by cutaneous B‐cell lymphomas (CBCL). This study aimed to assess the incidence and survival rates of PCL in Germany. Methods We analyzed data from the North Rhine‐Westphalia Cancer Registry (2008–2021), which covers a population of
Khodr Cheikh El Najjarine   +4 more
wiley   +1 more source

Progress [PDF]

open access: yes, 1989
Magazine reporting on the activities and programs of the University Hospital at Boston University Medical ...
Office of Publication Services, Boston University Medical Center
core  

Immune Monitoring Assay for Extracorporeal Photopheresis Treatment Optimization After Heart Transplantation [PDF]

open access: yes, 2023
Background: Extracorporeal photopheresis (ECP) induces immunological changes that lead to a reduced risk of transplant rejection. The aim of the present study was to determine optimum conditions for ECP treatment by analyzing a variety of ...
Ayuk, Francis Ayuketang   +9 more
core   +1 more source

Home - About - Disclaimer - Privacy